These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 31710966)
1. HIF-mediated Suppression of DEPTOR Confers Resistance to mTOR Kinase Inhibition in Renal Cancer. Doan H; Parsons A; Devkumar S; Selvarajah J; Miralles F; Carroll VA iScience; 2019 Nov; 21():509-520. PubMed ID: 31710966 [TBL] [Abstract][Full Text] [Related]
2. DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis. Ding Y; Shan L; Nai W; Lin X; Zhou L; Dong X; Wu H; Xiao M; Zhou X; Wang L; Li T; Fu Y; Lin Y; Jia C; Dai M; Bai X Cell Physiol Biochem; 2018; 46(2):520-531. PubMed ID: 29614494 [TBL] [Abstract][Full Text] [Related]
3. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma. Yao H; Tang H; Zhang Y; Zhang QF; Liu XY; Liu YT; Gu WT; Zheng YZ; Shang HB; Wang Y; Huang JY; Wei YX; Zhang X; Zhang J; Wu ZB Cancer Lett; 2019 Sep; 459():135-144. PubMed ID: 31176743 [TBL] [Abstract][Full Text] [Related]
7. DEPTOR in Skeletal Development and Diseases. Perez-Tejeiro JM; Csukasi F Front Genet; 2021; 12():667283. PubMed ID: 34122519 [TBL] [Abstract][Full Text] [Related]
8. Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression. Das F; Ghosh-Choudhury N; Lee DY; Gorin Y; Kasinath BS; Choudhury GG PLoS One; 2018; 13(11):e0207285. PubMed ID: 30444896 [TBL] [Abstract][Full Text] [Related]
9. Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein. Li T; Kuang T; Yang Z; Zhang Q; Zhang W; Fan Y Front Cell Dev Biol; 2021; 9():633035. PubMed ID: 34540820 [TBL] [Abstract][Full Text] [Related]
10. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma. Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway. Hu B; Lv X; Gao F; Chen S; Wang S; Qing X; Liu J; Wang B; Shao Z Onco Targets Ther; 2017; 10():4379-4391. PubMed ID: 28932123 [TBL] [Abstract][Full Text] [Related]
12. OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR. Zhao L; Wang X; Yu Y; Deng L; Chen L; Peng X; Jiao C; Gao G; Tan X; Pan W; Ge X; Wang P J Biol Chem; 2018 Mar; 293(13):4883-4892. PubMed ID: 29382726 [TBL] [Abstract][Full Text] [Related]
13. Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism. Danielpour D; Corum S; Leahy P; Bangalore A Curr Res Pharmacol Drug Discov; 2022; 3():100117. PubMed ID: 35992379 [TBL] [Abstract][Full Text] [Related]
14. Loss of hepatic DEPTOR alters the metabolic transition to fasting. Caron A; Mouchiroud M; Gautier N; Labbé SM; Villot R; Turcotte L; Secco B; Lamoureux G; Shum M; Gélinas Y; Marette A; Richard D; Sabatini DM; Laplante M Mol Metab; 2017 May; 6(5):447-458. PubMed ID: 28462079 [TBL] [Abstract][Full Text] [Related]
15. DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity. Cui D; Dai X; Gong L; Chen X; Wang L; Xiong X; Zhao Y Cell Death Dis; 2020 Nov; 11(11):976. PubMed ID: 33184290 [TBL] [Abstract][Full Text] [Related]
16. Regulation of human mTOR complexes by DEPTOR. Wälchli M; Berneiser K; Mangia F; Imseng S; Craigie LM; Stuttfeld E; Hall MN; Maier T Elife; 2021 Sep; 10():. PubMed ID: 34519268 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma. Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556 [TBL] [Abstract][Full Text] [Related]
18. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis. Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358 [TBL] [Abstract][Full Text] [Related]
19. Exploring novel and potent molecules for disrupting DEPTOR-mTOR interaction through structure-steered screening, extra-exactitude molecular docking, prime binding free energy estimation and voguish molecular dynamics. Shah BA; Ganai SA; Koul AM; Mohan S; Amin A; Wani Z; Majeed U; Rajamanikandan S; Farooq F; Malik FA; Shah NN; Qadri RA J Biomol Struct Dyn; 2022; 40(22):12037-12047. PubMed ID: 34431457 [TBL] [Abstract][Full Text] [Related]
20. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress. Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]